Base de dados : MEDLINE
Pesquisa : I01.615.500.250 [Categoria DeCS]
Referências encontradas : 19638 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 1964 ir para página                         

  1 / 19638 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29388757
[Au] Autor:Jalal S; Khan NU; Younis MZ
[Ti] Título:Effect of GNI on Infant Mortality Rate in Low Income, Lower Middle Income, Upper Middle Income and High Income Countries.
[So] Source:J Health Hum Serv Adm;39(2):159-85, 2016.
[Is] ISSN:1079-3739
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Global disparities in health form a complex issue adversely affecting much of the world's population. What has been found is that national income and other general socio-economic factors are strong determinants of population health (Houweling, 2005 & Schell, 2007). In countries where resources are less, people are much less healthy than people living in rich countries. In wealthier countries that have made immense progress in health indicators, the resulting change in age structure and morbidity and mortality patterns portends even greater financial demands on the health sector. This study noted the trends in several health indicators versus economic indicators and related it to low income, lower middle income, upper middle income and high income countries. We noted that there is improvement in all health indicators along with an increasing GNI per Capita and GDP. In low income regions though, the rate of improvement is slower as opposed to high income countries. However, there is progress, which is leading to an increase in aging population.
[Mh] Termos MeSH primário: Saúde Global
Produto Interno Bruto
Disparidades nos Níveis de Saúde
Renda/estatística & dados numéricos
Mortalidade Infantil/tendências
[Mh] Termos MeSH secundário: Países Desenvolvidos/economia
Países em Desenvolvimento/economia
Indicadores Básicos de Saúde
Seres Humanos
Lactente
Recém-Nascido
Expectativa de Vida
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180227
[Lr] Data última revisão:
180227
[Sb] Subgrupo de revista:H
[Da] Data de entrada para processamento:180202
[St] Status:MEDLINE


  2 / 19638 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29360884
[Au] Autor:Adams NL; Rose TC; Hawker J; Violato M; O'Brien SJ; Barr B; Howard VJK; Whitehead M; Harris R; Taylor-Robinson DC
[Ad] Endereço:NIHR Health Protection Research Unit in Gastrointestinal Infections, Liverpool, United Kingdom.
[Ti] Título:Relationship between socioeconomic status and gastrointestinal infections in developed countries: A systematic review and meta-analysis.
[So] Source:PLoS One;13(1):e0191633, 2018.
[Is] ISSN:1932-6203
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: The association between socioeconomic status (SES) and health is well-documented; however limited evidence on the relationship between SES and gastrointestinal (GI) infections exists, with published studies producing conflicting results. This systematic review aimed to assess the association between SES and GI infection risk, and explore possible sources of heterogeneity in effect estimates reported in the literature. METHODS: MEDLINE, Scopus, Web of Science and grey literature were searched from 1980 to October 2015 for studies reporting an association between GI infections and SES in a representative population sample from a member-country of the Organisation for Economic Co-operation and Development. Harvest plots and meta-regression were used to investigate potential sources of heterogeneity such as age; level of SES variable; GI infection measurement; and predominant mode of transmission. The protocol was registered on PROSPERO: CRD42015027231. RESULTS: In total, 6021 studies were identified; 102 met the inclusion criteria. Age was identified as the only statistically significant potential effect modifier of the association between SES and GI infection risk. For children, GI infection risk was higher for those of lower SES versus high (RR 1.51, 95% CI;1.26-1.83), but there was no association for adults (RR 0.79, 95% CI;0.58-1.06). In univariate analysis, the increased risk comparing low and high SES groups was significantly higher for pathogens spread by person-to-person transmission, but lower for environmental pathogens, as compared to foodborne pathogens. CONCLUSIONS: Disadvantaged children, but not adults, have greater risk of GI infection compared to their more advantaged counterparts. There was high heterogeneity and many studies were of low quality. More high quality studies are needed to investigate the association between SES and GI infection risk, and future research should stratify analyses by age and pathogen type. Gaining further insight into this relationship will help inform policies to reduce inequalities in GI illness in children.
[Mh] Termos MeSH primário: Gastroenteropatias/epidemiologia
Infecção/epidemiologia
Classe Social
[Mh] Termos MeSH secundário: Países Desenvolvidos
Seres Humanos
[Pt] Tipo de publicação:JOURNAL ARTICLE; META-ANALYSIS; RESEARCH SUPPORT, NON-U.S. GOV'T; REVIEW
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180226
[Lr] Data última revisão:
180226
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:180124
[St] Status:MEDLINE
[do] DOI:10.1371/journal.pone.0191633


  3 / 19638 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29317459
[Au] Autor:Battersby C; Santhalingam T; Costeloe K; Modi N
[Ad] Endereço:Department of Medicine, Neonatal Data Analysis Unit, Section of Neonatal Medicine, Chelsea and Westminster campus, Imperial College London, London, UK.
[Ti] Título:Incidence of neonatal necrotising enterocolitis in high-income countries: a systematic review.
[So] Source:Arch Dis Child Fetal Neonatal Ed;103(2):F182-F189, 2018 Mar.
[Is] ISSN:1468-2052
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: To conduct a systematic review of neonatal necrotising enterocolitis (NEC) rates in high-income countries published in peer-reviewed journals. METHODS: We searched MEDLINE, Embase and PubMed databases for observational studies published in peer-reviewed journals. We selected studies reporting national, regional or multicentre rates of NEC in 34 Organisation for Economic Co-operation and Development countries. Two investigators independently screened studies against predetermined criteria. For included studies, we extracted country, year of publication in peer-reviewed journal, study time period, study population inclusion and exclusion criteria, case definition, gestation or birth weight-specific NEC and mortality rates. RESULTS: Of the 1888 references identified, 120 full manuscripts were reviewed, 33 studies met inclusion criteria, 14 studies with the most recent data from 12 countries were included in the final analysis. We identified an almost fourfold difference, from 2% to 7%, in the rate of NEC among babies born <32 weeks' gestation and an almost fivefold difference, from 5% to 22%, among those with a birth weight <1000 g but few studies covered the entire at-risk population. The most commonly applied definition was Bell's stage ≥2, which was used in seven studies. Other definitions included Bell's stage 1-3, definitions from the Centers for Disease Control and Prevention, International Classification for Diseases and combinations of clinical and radiological signs as specified by study authors. CONCLUSION: The reasons for international variation in NEC incidence are an important area for future research. Reliable inferences require clarity in defining population coverage and consistency in the case definition applied. PROSPERO INTERNATIONAL PROSPECTIVE REGISTER OF SYSTEMATIC REVIEWS REGISTRATION NUMBER: CRD42015030046.
[Mh] Termos MeSH primário: Países Desenvolvidos/estatística & dados numéricos
Enterocolite Necrosante/epidemiologia
Doenças do Recém-Nascido/epidemiologia
[Mh] Termos MeSH secundário: Seres Humanos
Incidência
Recém-Nascido
Recém-Nascido Prematuro
Doenças do Prematuro/epidemiologia
Recém-Nascido de muito Baixo Peso
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180226
[Lr] Data última revisão:
180226
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180111
[St] Status:MEDLINE
[do] DOI:10.1136/archdischild-2017-313880


  4 / 19638 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29189818
[Au] Autor:Eisenstein M
[Ad] Endereço:Michael Eisenstein is a freelance science writer in Philadelphia, Pennsylvania.
[Ti] Título:How social scientists can help to shape climate policy.
[So] Source:Nature;551(7682), 2017 11 30.
[Is] ISSN:1476-4687
[Cp] País de publicação:England
[La] Idioma:eng
[Mh] Termos MeSH primário: Pegada de Carbono/economia
Pegada de Carbono/estatística & dados numéricos
Tomada de Decisões
Política Ambiental/tendências
Aquecimento Global/legislação & jurisprudência
Aquecimento Global/prevenção & controle
Ciências Sociais/tendências
Fatores Socioeconômicos
[Mh] Termos MeSH secundário: Pegada de Carbono/legislação & jurisprudência
Países Desenvolvidos/economia
Países Desenvolvidos/estatística & dados numéricos
Países em Desenvolvimento/economia
Países em Desenvolvimento/estatística & dados numéricos
Desenvolvimento Econômico
Características da Família
Aquecimento Global/economia
Seres Humanos
Estilo de Vida
Pobreza/economia
Pobreza/psicologia
Pobreza/estatística & dados numéricos
Classe Social
Impostos/legislação & jurisprudência
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180216
[Lr] Data última revisão:
180216
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171201
[St] Status:MEDLINE
[do] DOI:10.1038/d41586-017-07418-y


  5 / 19638 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29253412
[Au] Autor:Attaei MW; Khatib R; McKee M; Lear S; Dagenais G; Igumbor EU; AlHabib KF; Kaur M; Kruger L; Teo K; Lanas F; Yusoff K; Oguz A; Gupta R; Yusufali AM; Bahonar A; Kutty R; Rosengren A; Mohan V; Avezum A; Yusuf R; Szuba A; Rangarajan S; Chow C; Yusuf S; PURE study investigators
[Ad] Endereço:Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
[Ti] Título:Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data.
[So] Source:Lancet Public Health;2(9):e411-e419, 2017 Sep.
[Is] ISSN:2468-2667
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Hypertension is considered the most important risk factor for cardiovascular diseases, but its control is poor worldwide. We aimed to assess the availability and affordability of blood pressure-lowering medicines, and the association with use of these medicines and blood pressure control in countries at varying levels of economic development. METHODS: We analysed the availability, costs, and affordability of blood pressure-lowering medicines with data recorded from 626 communities in 20 countries participating in the Prospective Urban Rural Epidemiological (PURE) study. Medicines were considered available if they were present in the local pharmacy when surveyed, and affordable if their combined cost was less than 20% of the households' capacity to pay. We related information about availability and affordability to use of these medicines and blood pressure control with multilevel mixed-effects logistic regression models, and compared results for high-income, upper-middle-income, lower-middle-income, and low-income countries. Data for India are presented separately because it has a large generic pharmaceutical industry and a higher availability of medicines than other countries at the same economic level. FINDINGS: The availability of two or more classes of blood pressure-lowering drugs was lower in low-income and middle-income countries (except for India) than in high-income countries. The proportion of communities with four drug classes available was 94% in high-income countries (108 of 115 communities), 76% in India (68 of 90), 71% in upper-middle-income countries (90 of 126), 47% in lower-middle-income countries (107 of 227), and 13% in low-income countries (nine of 68). The proportion of households unable to afford two blood pressure-lowering medicines was 31% in low-income countries (1069 of 3479 households), 9% in middle-income countries (5602 of 65 471), and less than 1% in high-income countries (44 of 10 880). Participants with known hypertension in communities that had all four drug classes available were more likely to use at least one blood pressure-lowering medicine (adjusted odds ratio [OR] 2·23, 95% CI 1·59-3·12); p<0·0001), combination therapy (1·53, 1·13-2·07; p=0·054), and have their blood pressure controlled (2·06, 1·69-2·50; p<0·0001) than were those in communities where blood pressure-lowering medicines were not available. Participants with known hypertension from households able to afford four blood pressure-lowering drug classes were more likely to use at least one blood pressure-lowering medicine (adjusted OR 1·42, 95% CI 1·25-1·62; p<0·0001), combination therapy (1·26, 1·08-1·47; p=0·0038), and have their blood pressure controlled (1·13, 1·00-1·28; p=0·0562) than were those unable to afford the medicines. INTERPRETATION: A large proportion of communities in low-income and middle-income countries do not have access to more than one blood pressure-lowering medicine and, when available, they are often not affordable. These factors are associated with poor blood pressure control. Ensuring access to affordable blood pressure-lowering medicines is essential for control of hypertension in low-income and middle-income countries. FUNDING: Population Health Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Canadian Institutes of Health Research Strategy for Patient Oriented Research through the Ontario SPOR Support Unit, the Ontario Ministry of Health and Long-Term Care, pharmaceutical companies (with major contributions from AstraZeneca [Canada], Sanofi Aventis [France and Canada], Boehringer Ingelheim [Germany amd Canada], Servier, and GlaxoSmithKline), Novartis and King Pharma, and national or local organisations in participating countries.
[Mh] Termos MeSH primário: Anti-Hipertensivos/economia
Anti-Hipertensivos/provisão & distribuição
Países Desenvolvidos
Países em Desenvolvimento
Hipertensão/tratamento farmacológico
[Mh] Termos MeSH secundário: Idoso
Anti-Hipertensivos/uso terapêutico
Feminino
Seres Humanos
Renda/estatística & dados numéricos
Masculino
Meia-Idade
Resultado do Tratamento
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antihypertensive Agents)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180213
[Lr] Data última revisão:
180213
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171219
[St] Status:MEDLINE


  6 / 19638 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:27770797
[Au] Autor:Dawson A; Bateson D; Estoesta J; Sullivan E
[Ad] Endereço:Faculty of Health, University of Technology, Sydney (UTS), P.O. Box 123, Ultimo, NSW 2007, Sydney, NSW, Australia. angela.dawson@uts.edu.au.
[Ti] Título:Towards comprehensive early abortion service delivery in high income countries: insights for improving universal access to abortion in Australia.
[So] Source:BMC Health Serv Res;16(1):612, 2016 10 22.
[Is] ISSN:1472-6963
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Improving access to safe abortion is an essential strategy in the provision of universal access to reproductive health care. Australians are largely supportive of the provision of abortion and its decriminalization. However, the lack of data and the complex legal and service delivery situation impacts upon access for women seeking an early termination of pregnancy. There are no systematic reviews from a health services perspective to help direct health planners and policy makers to improve access comprehensive medical and early surgical abortion in high income countries. This review therefore aims to identify quality studies of abortion services to provide insight into how access to services can be improved in Australia. METHODS: We undertook a structured search of six bibliographic databases and hand-searching to ascertain peer reviewed primary research in English between 2005 and 2015. Qualitative and quantitative study designs were deemed suitable for inclusion. A deductive content analysis methodology was employed to analyse selected manuscripts based upon a framework we developed to examine access to early abortion services. RESULTS: This review identified the dimensions of access to surgical and medical abortion at clinic or hospital-outpatient based abortion services, as well as new service delivery approaches utilising a remote telemedicine approach. A range of factors, mostly from studies in the United Kingdom and United States of America were found to facilitate improved access to abortion, in particular, flexible service delivery approaches that provide women with cost effective options and technology based services. Standards, recommendations and targets were also identified that provided services and providers with guidance regarding the quality of abortion care. CONCLUSIONS: Key insights for service delivery in Australia include the: establishment of standards, provision of choice of procedure, improved provider education and training and the expansion of telemedicine for medical abortion. However, to implement such directives leadership is required from Australian medical, nursing, midwifery and pharmacy practitioners, academic faculties and their associated professional associations. In addition, political will is needed to nationally decriminalise abortion and ensure dedicated public provision that is based on comprehensive models tailored for all populations.
[Mh] Termos MeSH primário: Aborto Induzido/normas
Acesso aos Serviços de Saúde/normas
[Mh] Termos MeSH secundário: Instituições de Assistência Ambulatorial/normas
Austrália
Canadá
Assistência à Saúde
Países Desenvolvidos
Feminino
Seres Humanos
Renda
Liderança
Tocologia
Nova Zelândia
Satisfação do Paciente
Gravidez
Federação Russa
Telemedicina/normas
Reino Unido
Estados Unidos
Cobertura Universal
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE; META-ANALYSIS; REVIEW
[Em] Mês de entrada:1709
[Cu] Atualização por classe:180117
[Lr] Data última revisão:
180117
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161025
[St] Status:MEDLINE


  7 / 19638 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28450704
[Au] Autor:Ossio R; Roldán-Marín R; Martínez-Said H; Adams DJ; Robles-Espinoza CD
[Ad] Endereço:Laboratorio Internacional de Investigación sobre el Genoma Humano, Universidad Nacional Autónoma de México, Campus Juriquilla, Blvd Juriquilla 3001, Santiago de Querétaro 76230, México.
[Ti] Título:Melanoma: a global perspective.
[So] Source:Nat Rev Cancer;17(7):393-394, 2017 07.
[Is] ISSN:1474-1768
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:Most of our current knowledge of melanoma is derived from the study of patients from populations of European descent, for whom public health, sun protection initiatives and screening measures have appreciably decreased disease mortality. Notably, some melanoma subtypes that most commonly develop in other populations are not associated with exposure to ultraviolet (UV) light, suggesting a different disease aetiology. Further study of these subtypes is necessary to understand their risk factors and genomic architecture, and to tailor therapies and public health campaigns to benefit patients of all ethnic groups.
[Mh] Termos MeSH primário: Países Desenvolvidos
Países em Desenvolvimento
Promoção da Saúde
Melanoma/genética
Neoplasias Cutâneas/genética
[Mh] Termos MeSH secundário: Grupos de Populações Continentais
Saúde Global
Seres Humanos
Melanoma/epidemiologia
Melanoma/patologia
Melanoma/prevenção & controle
Neoplasias Cutâneas/epidemiologia
Neoplasias Cutâneas/patologia
Neoplasias Cutâneas/prevenção & controle
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1708
[Cu] Atualização por classe:180116
[Lr] Data última revisão:
180116
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170429
[St] Status:MEDLINE
[do] DOI:10.1038/nrc.2017.43


  8 / 19638 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29244823
[Au] Autor:Nghiem S; Graves N; Barnett A; Haden C
[Ad] Endereço:Institute of Health and Biomedical Innovation Queensland University of Technology, Brisbane, Queensland, Australia.
[Ti] Título:Cost-effectiveness of national health insurance programs in high-income countries: A systematic review.
[So] Source:PLoS One;12(12):e0189173, 2017.
[Is] ISSN:1932-6203
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVES: National health insurance is now common in most developed countries. This study reviews the evidence and synthesizes the cost-effectiveness information for national health insurance or disability insurance programs across high-income countries. DATA SOURCES: A literature search using health, economics and systematic review electronic databases (PubMed, Embase, Medline, Econlit, RepEc, Cochrane library and Campbell library), was conducted from April to October 2015. STUDY SELECTION: Two reviewers independently selected relevant studies by applying screening criteria to the title and keywords fields, followed by a detailed examination of abstracts. DATA EXTRACTION: Studies were selected for data extraction using a quality assessment form consisting of five questions. Only studies with positive answers to all five screening questions were selected for data extraction. Data were entered into a data extraction form by one reviewer and verified by another. EVIDENCE SYNTHESIS: Data on costs and quality of life in control and treatment groups were used to draw distributions for synthesis. We chose the log-normal distribution for both cost and quality-of-life data to reflect non-negative value and high skew. The results were synthesized using a Monte Carlo simulation, with 10,000 repetitions, to estimate the overall cost-effectiveness of national health insurance programs. RESULTS: Four studies from the United States that examined the cost-effectiveness of national health insurance were included in the review. One study examined the effects of medical expenditure, and the remaining studies examined the cost-effectiveness of health insurance reforms. The incremental cost-effectiveness ratio (ICER) ranged from US$23,000 to US$64,000 per QALY. The combined results showed that national health insurance is associated with an average incremental cost-effectiveness ratio of US$51,300 per quality-adjusted life year (QALY). Based on the standard threshold for cost-effectiveness, national insurance programs are cost-effective interventions. CONCLUSIONS: Although national health insurance programs have been introduced in most developed countries, only a few studies have examined their cost-effectiveness. All the selected studies revealed strong evidence to support health insurance programs or health reforms in the United States. The average ICER in this study is below the standard threshold for cost-effectiveness used in the US. The small number of relevant studies is the main limitation of this study.
[Mh] Termos MeSH primário: Análise Custo-Benefício/estatística & dados numéricos
Países Desenvolvidos/economia
Programas Nacionais de Saúde/economia
Anos de Vida Ajustados por Qualidade de Vida
[Mh] Termos MeSH secundário: Seres Humanos
Método de Monte Carlo
Qualidade de Vida
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180108
[Lr] Data última revisão:
180108
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171216
[St] Status:MEDLINE
[do] DOI:10.1371/journal.pone.0189173


  9 / 19638 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29179414
[Au] Autor:Debono B; Sabatier P; Garnault V; Hamel O; Bousquet P; Lescure JP; Plas JY
[Ad] Endereço:Neurosurgery Department, CAPIO-Clinique des Cèdres, Cornebarrieu, France. Electronic address: bdebono@gmail.com.
[Ti] Título:In Reply to the Letter to the Editor "Ambulatory Surgery and Social Inequalities in Industrialized Countries".
[So] Source:World Neurosurg;108:966, 2017 12.
[Is] ISSN:1878-8769
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Procedimentos Cirúrgicos Ambulatórios
Países Desenvolvidos
[Mh] Termos MeSH secundário: Seres Humanos
Fatores Socioeconômicos
[Pt] Tipo de publicação:LETTER; COMMENT
[Em] Mês de entrada:1712
[Cu] Atualização por classe:171215
[Lr] Data última revisão:
171215
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171129
[St] Status:MEDLINE


  10 / 19638 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29179413
[Au] Autor:Gaucher S; Maladry D; Bouam S; Martin A; Agostini C; Béthoux JP; Philippe HJ
[Ad] Endereço:University Paris Descartes, Paris Sorbonne Cité, Paris, France; Service of General, Plastic, and Ambulatory Surgery, Hospital Cochin, Paris, France. Electronic address: sonia.gaucher@aphp.fr.
[Ti] Título:Ambulatory Surgery and Social Inequalities in Industrialized Countries.
[So] Source:World Neurosurg;108:965, 2017 12.
[Is] ISSN:1878-8769
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Procedimentos Cirúrgicos Ambulatórios
Países Desenvolvidos
[Mh] Termos MeSH secundário: Seres Humanos
Fatores Socioeconômicos
[Pt] Tipo de publicação:LETTER; COMMENT
[Em] Mês de entrada:1712
[Cu] Atualização por classe:171214
[Lr] Data última revisão:
171214
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171129
[St] Status:MEDLINE



página 1 de 1964 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde